Biotechnology

Novel Feeder Cell Line Dramatically Expands NK Cell Pro...

A new feeder cell line multiplies NK cells by more than 100,000-fold in one mont...

Biotech at 50: Can the innovation ecosystem deliver the...

Biotechnology’s first 50 years were built on a uniquely American formula: world-...

California Still Golden Despite Job Losses: Industry Group

BIOCOM California quantified the economic impact of the Golden State’s life scie...

Gene Editing Pioneer Sangamo Files for Chapter 11 Bankr...

Eli Lilly has agreed to acquire Sangamo’s capsid delivery platform, zinc finger ...

BIO 2026: As capital returns, focus on quality over qua...

“Last year was a very business-as-usual year,” said Daniel Chancellor, VP of Tho...

BIO 2026: Gary Sinise, Marcus Freeman on leadership, se...

Leadership is often defined by how people respond to adversity. That theme ran t...

BIO 2026: Biotech dealmakers navigate uncertainty, purs...

From billion-dollar acquisitions to early-stage collaborations, biotech dealmaki...

Nextgen Platform Combines VectorBuilder and Maxcyte Tec...

The aim of the partnership is to provide a platform delivering high-end performa...

Nvidia Unveils Science Reasoning AI Suite with BioNeMo ...

The toolkit turns complex scientific workflows into agent-executable tasks and h...

Three Subtypes of Severe Pneumonia Might Inform Persona...

An analysis of human lung fluid samples from hospitalized patients identified th...

Cytomos’ AuraCyt Digital Predictive Cell Analytics Plat...

Cytomos says its benchtop cell analytics intelligence system combines the compac...

BIO 2026: Where AI is delivering – and where biotech mu...

Artificial Intelligence is on the lips of everyone at the 2026 BIO International...

BIO 2026: The business of biotech runs on partnerships

A $2.5 billion biotech AI deal announced at the beginning of the 2026 BIO Intern...

Long‑Range Gene Networks Uncover 641 New Schizophrenia‑...

A new gene‑network modeling framework integrating cis and trans regulatory effec...

AI Discovers Potential Antimicrobial “Prionin” Peptides

Researchers used AI to discover antibiotic-like molecules inside prion and prion...

AbbVie to Acquire Apogee Therapeutics for $10.9B

Apogee’s lead candidate zumilokibart, an IL-13 inhibitor also called APG777, is ...